GABY Inc. is a publicly traded cannabis company, listed on the CSE and OTCQB. By the end of 2022, the company plans to expand to additional retail locations, eventually becoming a dominant player in the California market.

The company’s flagship Mankind Dispensary serves nearly 30,000 shoppers per month, has a robust delivery and curbside pickup program, and stocks more than 700 unique products at any time, including GABY’s Kind Republic flower, prerolls, and extracts.

GABY’s leadership team of retail and cannabis experts curate industry-leading experiences which celebrate cannabis culture, and introduces customers to some of the best cannabis in the world.

By operating an expanding portfolio of brands and dispensaries, GABY is building a consumer-focused ecosystem that keeps shoppers happy, prices accessible, and builds lifelong connections between brands and their consumers.

Gemina Labs is a biosensor and diagnostic company with a unique and transformative proprietary biochemistry that significantly improves the performance of human and animal testings, including COVID-19, Influenza and other viruses.

Global Health Clinics operates a two-part system of customer lead generation and conversion, through its network of pavilions and the ownership and operation of five medical clinics that aim to connect Canadians with ACMPR license producers by advancing the understanding of medical cannabis and its applications, and the provision of related services and products for patients suffering from illness from which they may find relief with medical cannabis, including facilitating access to qualified health care practitioners, independent medical cannabis evaluations and related advice. Through its pavilions, the company is developing a substantive consumer database of persons interested in both medicinal and recreational use

Goodness Growth is a United States-based multi-state cannabis company with significant operations in our three core markets of Maryland, Minnesota, and New York. We are science-focused and dedicated to providing patients and adult-use customers with high quality cannabis-based products. We cultivate cannabis in environmentally friendly greenhouses, manufacture pharmaceutical-grade cannabis extracts, and sell our products at both Company-owned and third-party dispensaries to qualifying patients and adult-use customers. We currently serve thousands of customers each month.

In addition to the listed Subordinate Voting Shares, there are 348,642 Multiple Voting Shares issued and outstanding. Each Multiple Voting Share is convertible into 100 Subordinate Voting Shares at the option of the holder or upon certain triggering events. This number also includes Subordinate Voting Shares underlying existing and proposed convertible securities.